Capital, Strength

Capital Strength and Insider Buying at Munich Re Can't Dispel Pricing Concerns That Sank Shares to 52-Week Low

14.05.2026 - 04:31:19 | boerse-global.de

Despite €1.71B quarterly profit and 292% solvency, Munich Re shares hit 52-week low as competition intensifies, analysts cut targets, and premium income slips.

Capital Strength and Insider Buying at Munich Re Can't Dispel Pricing Concerns That Sank Shares to 52-Week Low - Foto: ĂĽber boerse-global.de
Capital Strength and Insider Buying at Munich Re Can't Dispel Pricing Concerns That Sank Shares to 52-Week Low - Foto: ĂĽber boerse-global.de

When a company posts a record quarterly profit of €1.71 billion — up nearly 57% from a year earlier — and boasts a solvency ratio of 292%, the stock market usually applauds. Not at Munich Re. The reinsurer's shares closed at €467.30 on Wednesday, a new 52-week low, and have lost almost 15% since the start of the year. The gap between operational strength and market sentiment has rarely been wider.

The culprit is a 3.1% decline in adjusted pricing during the 1 April renewal season, a signal that competition is intensifying in the property-and-casualty reinsurance market. Analysts have responded by slashing their price targets. RBC cut its target from €560 to €490, Citi from €593 to €511, Berenberg from €629 to €565, and Goldman Sachs trimmed to €557. All maintain neutral or hold ratings. The market is effectively pricing in a deteriorating environment even as the company delivers stellar numbers.

Munich Re's first-quarter results were flattered by an unusually low major-loss burden of just €130 million, compared with more than €1 billion a year earlier when the Los Angeles wildfires struck. That comparison flatters the net profit figure, but management is not banking on a repeat. The outlier allowance — the budget for large losses — has been raised by one percentage point to 18% of earned net insurance premiums, split between natural catastrophes (14.5%) and man-made events (3.5%). The full-year net profit target of €6.3 billion remains unchanged.

Underlying performance was solid across the board. ERGO contributed €235 million to the net result. The life and health reinsurance segment delivered a technical profit of €500 million, slightly above its proportionate annual path. The annualised return on equity reached 19.7%, well above the "Ambition 2030" strategic target. Investment income improved to €1.68 billion, with a running yield of 3.5% and a reinvestment yield of 4.2%.

Should investors sell immediately? Or is it worth buying MĂĽnchener RĂĽck?

Premium income, however, slipped. Total insurance revenue fell to roughly €15 billion from €15.8 billion, dragged down by negative currency effects of €162 million — though that was much less severe than last year’s currency hit. CFO Andrew Buchanan struck a confident note on the annual goal, but the revenue dip underscores the pricing headwinds.

Against that backdrop, the board has moved to demonstrate confidence. Several members bought shares in the open market on 12 and 13 May, after the stock had fallen below €500. The purchases are widely interpreted as a vote of faith in the company's prospects. Meanwhile, the first tranche of a new share buyback programme launched on Thursday, targeting up to €900 million of repurchases by 21 August 2026. That is part of a broader €2.25 billion buyback authorisation. The capital strength is such that the solvency ratio already accounts for both the planned dividend and the entire buyback programme.

The strategic trade-off is deliberate. At the April renewals, Munich Re cut its underwriting volume in Asian markets by 18.5%, preferring margin discipline over market share. The group sees a €15 billion global cyber insurance market as a growth avenue, with small and medium-sized companies becoming more aware of digital vulnerabilities. Yet the stock continues to price in a more pessimistic scenario.

MĂĽnchener RĂĽck at a turning point? This analysis reveals what investors need to know now.

The next test will be the major-loss experience in the coming quarters. If the low burden persists, the annual profit target looks achievable. But the share price, now nearly 23% below the year's high of €605, suggests the market expects the pricing cycle to worsen. The most bullish analyst target on the Street is €565 — offering potential upside of about 20% from current levels. Whether that gap closes depends on whether the market's fear or management's conviction proves correct.

Ad

MĂĽnchener RĂĽck Stock: New Analysis - 14 May

Fresh MĂĽnchener RĂĽck information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated MĂĽnchener RĂĽck analysis...

So schätzen die Börsenprofis Capital Aktien ein!

<b>So schätzen die Börsenprofis Capital Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | DE0008430026 | CAPITAL | boerse | 69329433 |